Andere Kunden interessierten sich auch für
![Myeloproliferative Neoplasms, an Issue of Hematology/Oncology Clinics of North America]( "Myeloproliferative Neoplasms, an Issue of Hematology/Oncology Clinics of North America")
Myeloproliferative Neoplasms, an Issue of Hematology/Oncology Clinics of North America128,99 €![Gene-Based Therapies for Pediatric Blood Diseases, an Issue of Hematology/Oncology Clinics of North America]( "Gene-Based Therapies for Pediatric Blood Diseases, an Issue of Hematology/Oncology Clinics of North America")
Gene-Based Therapies for Pediatric Blood Diseases, an Issue of Hematology/Oncology Clinics of North America131,99 €![Acute Leukemia, an Issue of Hematology/Oncology Clinics of North America]( "Acute Leukemia, an Issue of Hematology/Oncology Clinics of North America")
Acute Leukemia, an Issue of Hematology/Oncology Clinics of North America117,99 €![Gynecologic Cancer, an Issue of Hematology/Oncology Clinics of North America]( "Gynecologic Cancer, an Issue of Hematology/Oncology Clinics of North America")
Gynecologic Cancer, an Issue of Hematology/Oncology Clinics of North America117,99 €![Consultative Hematology, an Issue of Hematology/Oncology Clinics of North America]( "Consultative Hematology, an Issue of Hematology/Oncology Clinics of North America")
Consultative Hematology, an Issue of Hematology/Oncology Clinics of North America117,99 €![Thalassemia, an Issue of Hematology/Oncology Clinics of North America]( "Thalassemia, an Issue of Hematology/Oncology Clinics of North America")
Thalassemia, an Issue of Hematology/Oncology Clinics of North America116,99 €![New Drugs for Malignancy, an Issue of Hematology/Oncology Clinics of North America]( "New Drugs for Malignancy, an Issue of Hematology/Oncology Clinics of North America")
New Drugs for Malignancy, an Issue of Hematology/Oncology Clinics of North America117,99 €
Topics include: Clinical Predictors of Outcome in MPNs; Molecular pathogenesis of MPNs; Disordered signaling in MPNs; Role of TET2/ASXL1 in MPN Pathogenesis; Pathogenesis and treatment of systemic mastocytosis; Role of additional novel therapies in MPNs; Role of novel mutations in MPN pathogenesis and outcome; Role of JAK inhibitors in MPN treatment; Animal Models of MPNs; and Role of Germline Genetic Factors in MPN Pathogenesis.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.